Leptomeningeal and Medullary Response to Second-Line Erlotinib in Lung Adenocarcinoma
- 1 June 2008
- journal article
- case report
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 3 (6) , 677-679
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Recurrent responses to non-small cell lung cancer brain metastases with erlotinibLung Cancer, 2007
- Complete response to erlotinib treatment in brain metastases from recurrent NSCLCThorax, 2005
- Leptomeningeal carcinomatosisCancer Treatment Reviews, 1999
- Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.Journal of Clinical Oncology, 1993
- Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patientsCancer, 1982